Sub-Chronic Neuropathological and Biochemical Changes in Mouse Visual System after Repetitive Mild Traumatic Brain

Radouil Tzekov1,2,3, Clint Dawson1, Megan Orlando1

  • 1The Roskamp Institute, Sarasota, FL, United States of America.

Plos One
|April 19, 2016
PubMed

Insights

Repetitive mild traumatic brain injury (r-mTBI) causes optic nerve damage and retinal ganglion cell loss. Biochemical changes, including demyelination and altered proteins/lipids, were observed in mice three weeks post-injury.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Traumatic Brain Injury Research

Background:

  • Repetitive mild traumatic brain injury (r-mTBI) has known neuropathological and biochemical effects on the visual system.
  • Understanding these effects is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the consequences of r-mTBI on the retina and optic nerve in a mouse model.
  • To identify specific molecular and cellular changes associated with r-mTBI in the visual pathway.

Main Methods:

  • Utilized a mouse model of r-mTBI, with a control group receiving repetitive sham anesthesia.
  • Assessed retinal ganglion cell (RGC) number via histology and immunohistochemistry.
  • Analyzed optic nerve tissue for cellularity, myelin content, and performed proteomic and lipidomic analyses at 3 weeks post-injury.

Main Results:

  • r-mTBI mice showed increased optic nerve cellularity and demyelination compared to controls.
  • A significant decrease (~25%) in Brn3a-positive RGCs was observed in r-mTBI mice.
  • Proteomic and lipidomic analyses revealed alterations in proteins (e.g., neurofilaments, tubulin, heat shock proteins) and lipids (e.g., lysophosphatidylcholine) consistent with neuronal damage and demyelination.

Conclusions:

  • r-mTBI induces significant neuropathological and biochemical changes in the optic nerve and retina.
  • These findings correlate histological observations with molecular alterations, highlighting key affected pathways.
  • The study provides a basis for identifying therapeutic targets to mitigate visual deficits following r-mTBI.

Related Concept Videos